AM679 is a potent and selective FLAP inhibitor, demonstrating sub-nanomolar activity in binding and human leukotriene assays. It exhibits a favorable CYP profile with no time-dependent inhibition and provides strong oral efficacy in rodent models of airway inflammation, making it a valuable tool for researching leukotriene biosynthesis pathways in both in vitro and in vivo settings.
